KANTAR HEALTH BLOG

Pharma executives aiming to do business in Korea must take several key steps to ensure success in this prime growth market.

Taiwan is one of the top healthcare growth markets, successfully balancing rising healthcare costs and providing patients with access to affordable therapies. However, Taiwan faces several significant challenges including a lack of budget for innovative new medicines as well as barriers to patient accessibility.

As the second most populous country in the world, India faces a wide variety of health challenges across its diverse demographics. For pharma companies to achieve commercial success, a local presence and a comprehensive understanding of the Indian market nuances are a must for developing and executing a highly informed market access strategy.

Brazil is bursting with opportunities for pharma companies- but only those who understand this growth market's nuances will succeed.

Companies know a great deal about China today, but the key challenge is to make sense of potential opportunities and adapt business models accordingly.